Sudip Bandopadhyay, Market Expert told CNBC-TV18, "We have been bullish on Lupin for the last almost six months, we have been recommending our investors. I think that is a fantastic company. Pharma has got some problems, structural and otherwise. However, Lupin clearly stands out. They have a fantastic distribution and fantastic marketing strength in US. Their domestic business is doing well, they have got the right clearances from US FDA. Their largest facility in Goa has been cleared. So, overall things are working out for the company. Of course there are lots of challenges coming in the market as far as US is concerned but Lupin is best positioned to withstand those challenges. So, current price, we are still a buyer in Lupin.""As far Hero MotoCorp is concerned, the Budget does help it. If rural income increases and if money goes in the hands of the farmers and rural population, Hero will be the biggest beneficiary and that will get reflected over the next few months. The numbers have started turning good, they also got hit by demonetisation but they will start recovering," he said."I think we will still wait and watch. The valuations are not really congenial for buying Hero MotoCorp at this stage."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
